However, if as expected, these drugs lower long-term heart disease risks, then that will help with the insurance arguments, says de Lemos
Likewise, mothers who are breastfeeding are advised against NAD+ therapy because its unknown if or how NAD+ might pass into breast milk and affect the baby
Treating larger areas like the entire face or multiple body parts will typically be more expensive than targeting smaller areas like underarms and lips
Supplementary material Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made